Incidence and characteristics of hypotensive transfusion reaction: 10‐year experience in a single center

Hypotensive transfusion reaction (HyTR) is rare. It is characterized by a rapid onset of hypotension during transfusion, which usually resolves quickly upon cessation of transfusion. Information on the incidence and clinical characteristics of HyTR has been reported in only a few studies.

[1]  M. Sapiano,et al.  Transfusion‐associated adverse events and implementation of blood safety measures ‐ findings from the 2017 National Blood Collection and Utilization Survey , 2020, Transfusion.

[2]  R. Goel,et al.  Noninfectious transfusion-associated adverse events and their mitigation strategies. , 2019, Blood.

[3]  Joan Cid,et al.  Transfusion reactions: prevention, diagnosis, and treatment , 2016, The Lancet.

[4]  L. Goodnough,et al.  Clinical Pattern in Hypotensive Transfusion Reactions , 2016, Anesthesia and analgesia.

[5]  J. Lacroix,et al.  Incidence of hypotension and acute hypotensive transfusion reactions following platelet concentrate transfusions , 2016, Vox sanguinis.

[6]  S. Choi,et al.  Frequency and Pattern of Noninfectious Adverse Transfusion Reactions at a Tertiary Care Hospital in Korea , 2015, Annals of laboratory medicine.

[7]  A. Tobian,et al.  Hypotensive transfusion reactions in the era of prestorage leukoreduction , 2015, Transfusion.

[8]  A. Désormeaux,et al.  Acute hypotensive transfusion reaction during liver transplantation in a patient on angiotensin converting enzyme inhibitors from low aminopeptidase P activity , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  R. Colman,et al.  Generation of kinins during preparation and storage of whole blood–derived platelet concentrates , 2007, Transfusion.

[10]  N. Heddle,et al.  Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage , 2004, Transfusion.

[11]  V. Conti,et al.  Vasodilation and cardiopulmonary bypass: the role of bradykinin and the pulmonary vascular endothelium. , 2001, Chest.

[12]  D. Vaughan,et al.  Interactive Effect of Ethnicity and ACE Insertion/Deletion Polymorphism on Vascular Reactivity , 2001, Hypertension.

[13]  J. Rouleau,et al.  Bradykinin metabolism and hypotensive transfusion reactions , 2001, Transfusion.

[14]  K. Quillen.  Hypotensive transfusion reactions in patients taking angiotensin-converting-enzyme inhibitors. , 2000, The New England journal of medicine.

[15]  J. Lundahl,et al.  Kinetics of Bradykinin Levels during and after Leucocyte Filtration of Platelet Concentrates , 1998, Vox Sanguinis.

[16]  M. Dupuis,et al.  Hypotensive reactions to red cells filtered at the bedside, but not to those filtered before storage, in patients taking ACE inhibitors , 1998, Transfusion.

[17]  H. Abe,et al.  Hypotensive reactions with a white cell‐reduction filter: activation of kallikrein‐kinin cascade in a patient , 1998, Transfusion.

[18]  G. Leparc,et al.  Hypotensive Reactions Associated with Platelet Transfusions and Angiotensin-Converting Enzyme Inhibitors , 1998, Vox Sanguinis.

[19]  H. Abe,et al.  Bradykinin generation during filtration of platelet concentrates with a white cell‐reduction filter , 1995, Transfusion.

[20]  C. Tormey,et al.  The development of a novel molecular assay examining the role of aminopeptidase P polymorphisms in acute hypotensive transfusion reactions. , 2013, Archives of pathology & laboratory medicine.